Ophthalmic and surgical sutures for holding tissue together after medical procedures will no longer be made in Exeter Township, PA, thanks to the upcoming closure of the Surgical Specialties' manufacturing plant in the Philadelphia suburb. It will come at a cost of 254 jobs.
Last year, GlaxoSmithKline announced plans to slim down its Research Triangle Park, NC-based operations, chopping 900 jobs. Now, it's telling state officials that almost 200 workers are heading for the door.
Merck issued its WARN letter today on upcoming cuts at Cubist's Massachusetts operations, outlining plans to shutter its discovery and nondevelopment unit in Lexington, MA, and terminate 128 staffers.
Surgical Instrument provider Integra LifeSciences laid off 49 employees in Massachusetts as part of a cost-saving initiative, MassDevice reports, citing a public notice filed under the federal Worker Adjustment and Retraining Notification Act.
Boehringer Ingelheim's global restructuring--prompted by the German pharma's sales struggle--is now manifesting itself in Connecticut, where the company is laying off staffers in Ridgefield.
Just as it was spreading word of a big new development partnership this morning, Sanofi dropped the ax on about 100 employees in a reorganization of its R&D operations.
Following a 13% reduction in profit at Siemens Healthcare during the previous quarter, the conglomerate is reportedly planning to cut 7,400 jobs companywide in a bid to achieve cost savings of €1 billion.
Agilent Technologies is closing its nuclear magnetic resonance business, as the downsizing of its research products division continues. The move is expected to cost 300 jobs over the next 12 months in Santa Clara, CA, and Yarnton, England.
The second shift at St. Jude Medical's cardiology device manufacturing facility in Sylmar, a suburb of Los Angeles, is being eliminated, resulting in the loss of up 270 jobs. The layoffs will take effect July 28, reports the San Fernando Valley Business Journal.
Over the first few months of 2014, Novartis quietly began laying off workers, shedding an estimated 3,000 jobs in four months. Now BioSpace has provided details of where the ax has fallen and why, with development IT teams suffering heavy job losses.